Sbir FY24 concept award-drug repurposing for rare cancers using a large-scale, high-quality biomedical knowledge graph
Ended Definitive Contract Awarded
- Contract number
- 75N91024C00007
- Awardee
-
Insilicom LLC UEI UEZ1NQZ388J6
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $355,000
Award facts
- Opportunity
-
- National Cancer Institute (NCI) Small Business Innovation Research (SBIR) Innovative Concept Award Program – Fiscal Year 2024 Pre-Solicitation · 75N91023R00034 · Posted Feb 27, 2023
- Contract value 100% obligated
- $355,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 52 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Tallahassee, FL 32312, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services. The $355,000 Firm Fixed Price contract was awarded to Insilicom LLC, a minority-owned and woman-owned small business, to develop a proof-of-concept technology for drug repurposing targeting rare cancers using a large-scale, high-quality biomedical knowledge graph. The original contract opportunity was a total small business set-aside, seeking innovative technologies for the treatment, detection, and diagnosis of pediatric and rare cancers with 5-year survival rates less than 50%. Insilicom's work under this contract will leverage advanced artificial intelligence and knowledge graph approaches to transform unstructured scientific literature into structured, actionable knowledge to support more efficient drug discovery and medical research.
Quick answers
Who was awarded contract 75N91024C00007?
75N91024C00007 was awarded to Insilicom LLC by National Cancer Institute (National Institutes of Health) on February 15, 2024.
How much is contract 75N91024C00007 worth?
The government has obligated $355,000 on 75N91024C00007.
Was contract 75N91024C00007 competed?
The extent of competition for 75N91024C00007 was full and open competition after exclusion of sources. The government received 52 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award